Magnesio Solfato S.A.L.F

Magnesium sulfate, the active ingredient in Magnesio Solfato S.A.L.F, is an electrolyte presented as a sterile solution for intramuscular and intravenous use. It is employed to correct magnesium deficiency and to manage conditions such as eclampsia, cardiac arrhythmias, severe asthma attacks, and hypocalcemia in hospital settings.

GNH USA supplies Magnesio Solfato S.A.L.F as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Magnesio Solfato S.A.L.F is used in clinical situations that require rapid magnesium replacement or specific therapeutic effects related to magnesium deficiency and related disorders. - Magnesium deficiency: restores normal serum magnesium levels. - Eclampsia and preeclampsia: prevents seizures in pregnant patients. - Cardiac arrhythmias (e.g., torsades de pointes): stabilises cardiac electrical activity. - Severe asthma exacerbations: provides bronchodilatory support. - Hypocalcemia: assists in calcium homeostasis when used with calcium therapy.

Adverse reactions may occur with magnesium sulfate administration and should be monitored.

Common Side Effects: - Flushing or warmth at the injection site. - Nausea or vomiting. - Mild hypotension. - Headache. - Transient muscle weakness.

Serious or Rare Side Effects: - Respiratory depression or arrest. - Cardiac arrest or severe bradycardia. - Hypermagnesemia leading to loss of deep tendon reflexes. - Severe hypotension unresponsive to fluids. - Allergic reactions such as rash, urticaria, or anaphylaxis.

Magnesium sulfate should be used with caution in specific clinical contexts. - Renal impairment: monitor serum magnesium and adjust dosing. - Cardiac disease: observe cardiac rhythm continuously. - Neuromuscular disorders: assess for increased muscle weakness. - Pregnancy: use only when clearly indicated, as safety data are limited. - Drug interactions: review concomitant medications that affect magnesium levels. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Magnesium sulfate may interact with several medications, altering efficacy or safety.

Major Interactions (Avoid): - Calcium channel blockers: risk of additive hypotension. - Neuromuscular blocking agents: prolonged paralysis. - Certain antibiotics (e.g., tetracyclines, quinolones): reduced absorption when given concurrently.

Moderate Interactions (Monitor Closely): - Loop diuretics: may increase magnesium loss. - ACE inhibitors or ARBs: potential for enhanced hypermagnesemia. - Digoxin: monitor serum levels due to possible electrolyte shifts.